Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy
JAMA Network Open · 2023
DOI: 10.1001/jamanetworkopen.2023.4723 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, 2023. Verfasst von Achim Mortsiefer und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of General Practice and Primary Care, Chair of General Practice II and Patient-Centredness in Primary Care, Faculty of Health, Witten/Herde…. Hauptthemen laut MEDLINE: Deprescriptions, Frailty. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance For older adults with frailty syndrome, reducing polypharmacy may have utility as a safety-promoting treatment option.
Objective
To investigate the effects of family conferences on medication and clinical outcomes in community-dwelling older adults with frailty receiving polypharmacy. Design, Setting, and Participants This cluster randomized clinical trial was conducted from April 30, 2019, to June 30, 221, at 110 primary care practices in Germany. The study included community-dwelling adults aged 70 years or older with frailty syndrome, daily use of at least 5 different medications, a life expectancy of at least 6 months, and no moderate or severe dementia.
Interventions
General practitioners (GPs) in the intervention group received 3 training sessions on family conferences, a deprescribing guideline, and a toolkit with relevant nonpharmacologic interventions. Three GP-led family conferences for shared decision-making involving the participants and family caregivers and/or nursing services were subsequently held per patient at home over a period of 9 months. Patients in the control group received care as usual. Main Outcomes and Measures The primary outcome was the number of hospitalizations within 12 months, as assessed by nurses during home visits or telephone interviews. Secondary outcomes included the number of medications, the number of European Union list of the number of potentially inappropriate medication (EU[7]-PIM) for older people, and geriatric assessment parameters. Both per-protocol and intention-to-treat analyses were conducted.
Results
The baseline assessment included 521 individuals (356 women [68.3%]; mean [SD] age, 83.5 [6.17] years). The intention-to-treat analysis with 510 patients showed no significant difference in the adjusted mean (SD) number of hospitalizations between the intervention group (0.98 [1.72]) and the control group (0.99 [1.53]). In the per-protocol analysis including 385 individuals, the mean (SD) number of medications decreased from 8.98 (3.56) to 8.11 (3.21) at 6 months and to 8.49 (3.63) at 12 months in the intervention group and from 9.24 (3.44) to 9.32 (3.59) at 6 months and to 9.16 (3.42) at 12 months in the control group, with a statistically significant difference at 6 months in the mixed-effect Poisson regression model ( P = .001). After 6 months, the mean (SD) number of EU(7)-PIMs was significantly lower in the intervention group (1.30 [1.05]) than in the control group (1.71 [1.25]; P = .04). There was no significant difference in the mean number of EU(7)-PIMs after 12 months. Conclusions and Relevance In this cluster randomized clinical trial with older adults taking 5 or more medications, the intervention consisting of GP-led family conferences did not achieve sustainable effects in reducing the number of hospitalizations or the number of medications and EU(7)-PIMs after 12 months. Trial Registration German Clinical Trials Register: DRKS00015055
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of General Practice and Primary Care, Chair of General Practice II and Patient-Centredness in Primary Care, Faculty of Health, Witten/Herdecke University, Witten, Germany.
- Institute of General Practice, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
- Institute of General Practice, University Medical Center Rostock, Rostock, Germany.
- Department of Clinical Pharmacology, School of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany.
- Institute for Health and Nursing Science, Medical Faculty, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
- Institute for Health Services and Economics, Centre for Health and Society, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Zitieren
APA
Mortsiefer, A., Löscher, S., Pashutina, Y., Santos, S., Altiner, A., Drewelow, E., Ritzke, M., Wollny, A., Thürmann, P., Bencheva, V., Gogolin, M., Meyer, G., Abraham, J., Fleischer, S., Icks, A., Montalbo, J., Wiese, B., Wilm, S., & Feldmeier, G. (2023). Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.4723
Vancouver
Mortsiefer A, Löscher S, Pashutina Y, Santos S, Altiner A, Drewelow E, et al. Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy. JAMA Network Open. 2023. doi:10.1001/jamanetworkopen.2023.4723
BibTeX
@article{Mortsiefer2023,
author = {Mortsiefer, Achim and Löscher, Susanne and Pashutina, Yekaterina and Santos, Sara and Altiner, Attila and Drewelow, Eva and Ritzke, Manuela and Wollny, Anja and Thürmann, Petra and Bencheva, Veronika and Gogolin, Matthias and Meyer, Gabriele and Abraham, Jens and Fleischer, Steffen and Icks, Andrea and Montalbo, Joseph and Wiese, Birgitt and Wilm, Stefan and Feldmeier, Gregor},
title = {Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy},
journal = {JAMA Network Open},
year = {2023},
doi = {10.1001/jamanetworkopen.2023.4723}
}
EUVIMED